CoChat

Treatment of young patients with HNF1A mutations (HNF1A–MODY)

Raile, K., Schober, E., Konrad, K., Thon, A., Grulich‐Henn, J., Meissner, T., Wölfle, J., Scheuing, N., Holl, R. W., the DPV Initiative the German BMBF Competence Network Diabetes Mellitus · 2015 · Diabetic Medicine
Cited by 49

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aim: Children and adolescents with a molecular diagnosis of HNF1A–MODY should be treated with oral sulfonylurea according to current International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Methods: We surveyed the German–Austrian DPV database of 50 043 people and included 114 patients with a confirmed molecular–genetic diagnosis of HNF1A mutation and diabetes onset at below age 18 years. We analysed hypoglycaemic episodes, metabolic control (HbA 1c ) and other clinical variables according to treatment groups. Results: People with HNF1A–MODY were included and analysed according to treatment with insulin alone ( n = 34), sulfonylurea ( n = 30), meglitinides ( n = 22) or lifestyle ( n = 28). In those receiving any drug treatment ( n = 86), severe hypoglycaemia did not occur with meglitinide and was highest (at 3.6 events per 100 patient‐years) with insulin. HbA 1c was highest with insulin treatment (insulin = 58 mmol/mol, 7.5%; sulfonylurea = 55 mmol/mol, 7.2%; meglitinides = 52 mmol/mol, 6.9%; P = 0.008), whereas weight (BMI SD score), serum lipids and blood pressure were not different. Conclusions: Of note, 40% of people with HNF1A–MODY and medical treatment were receiving insulin alone and thus were not being treated in line with up‐to‐date International Society for Pediatric and Adolescent Diabetes/International Diabetes Federation guidelines, despite insulin treatment being associated with worse metabolic control and the risk of hypoglycaemia. The unlicensed use of oral drugs in patients below age 18 years and adherence by both doctors and patients to the initial insulin treatment might contribute to this finding.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.12662

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Raile, K., Schober, E., Konrad, K., Thon, A., Grulich‐Henn, J., Meissner, T., Wölfle, J., Scheuing, N., Holl, R. W., & the DPV Initiative the German BMBF Competence Network Diabetes Mellitus
Venue
Diabetic Medicine
Publisher
Wiley
Published
2014-12-30
Volume
32
Issue
4
Pages
526-530
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1995301252
Cited by
49
References
3
FWCI
1.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.